-
CSO and VP, R&D Clinical and Technology Solutions, Quest Diagnostics Nigel Clarke, CSO and VP of R&D Clinical and Technology Solutions at Quest Diagnostics, is an acclaimed scientist with over 2 decades of experience in the healthcare industry. His expertise in developing cutting-edge diagnostic assays is backed by a strong foundation in biomarkers, bioinformatics, GLP, protein chemistry, and liquid chromatography-mass spectrometry (LC-MS). Holding a PhD in Bioanalytical Mass Spectrometry from the University of Kent and a postdoctoral fellowship from the Mayo Clinic, Clarke’s career trajectory at Quest Diagnostics demonstrates his leadership and innovative approach in healthcare technology. From Principle Scientist at Schering-Plough Research Institute to his current role, he has significantly contributed to advancing diagnostic methodologies, embodying a blend of scientific acumen and visionary leadership in healthcare diagnostics. Clarke’s journey reflects his dedication to enhancing healthcare outcomes through technological innovation.
-
Executive Director, IVD and CDx, Quest Diagnostics Greg Baschkopf, currently the Executive Director of IVD and CDx at Quest Diagnostics, is a dynamic leader in the field of healthcare diagnostics. With a decade at Quest, his journey from medical technologist to his current executive role highlights his deep commitment to innovation in diagnostics. His expertise in molecular oncology, genetics, and solid tumor profiling, combined with his progression through various leadership roles, showcases his ability to drive impactful changes in clinical trials and diagnostic developments. Baschkopf’s educational background in biology from Boston University complements his professional achievements, underscoring his comprehensive understanding of the scientific and operational aspects of healthcare diagnostics. His career at Quest Diagnostics, marked by significant contributions to the field, reflects his dedication to advancing healthcare outcomes through innovative diagnostic solutions.
-
Sr. Director, CDx Programs, Quest Diagnostics Vijay Walia’s role as Senior Director of CDx Programs at Quest Diagnostics is a testament to his specialized focus in companion diagnostics and regulatory affairs, particularly within the niche of health technology. His journey, starting with foundational roles at the FDA, shaped his expertise in overseeing critical health technology projects. This background, coupled with his scientific training in pharmacology, has been integral to his success at Quest, where he drives innovations in diagnostic methodologies. His career illustrates a deep commitment to advancing specific areas of healthcare through a combination of regulatory knowledge and technical proficiency.
